Cargando…
Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?
The first successful live donor kidney transplant was performed in 1954. Receiving a kidney transplant from a live kidney donor remains the best option for increasing both life expectancy and quality of life in patients with end-stage kidney disease. However, ever since 1954, there have been multipl...
Autores principales: | Ferro, Charles J, Townend, Jonathan N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967677/ https://www.ncbi.nlm.nih.gov/pubmed/35371443 http://dx.doi.org/10.1093/ckj/sfab271 |
Ejemplares similares
-
Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
por: Ferro, Charles J, et al.
Publicado: (2021) -
The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019) -
Intravenous iron therapy and the cardiovascular system: risks and benefits
por: Del Vecchio, Lucia, et al.
Publicado: (2020) -
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis
por: Pisano, Anna, et al.
Publicado: (2021) -
Clinical relevance of abstruse transport phenomena in haemodialysis
por: Bowry, Sudhir K, et al.
Publicado: (2021)